Newsfeeds - Spark Newswire

1 minute read

Cathie Wood Sheds $5M In CRISPR Therapeutics, Scoops Up These Biotech Stocks Instead

Today, 3:12 AM

Cathie Wood-led Ark Investment Management on Thursday sold 70,723 shares of gene editing company CRISPR Therapeutics AG (NASDAQ: CRSP), valued at over $5.58 million, via its flagship fund.

ARKK

1 minute read

Pacific Biosciences Q2 EPS $(0.34) Misses $(0.32) Estimate, Sales $35.47M Miss $35.70M Estimate

By Bill Haddad

Today, 3:12 AM

Pacific Biosciences (NASDAQ:PACB) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.32) by 6.25 percent. This is a 61.9 percent decrease over losses of $(0.21) per share

PACB

1 minute read

Earnings

Pacific Biosciences: Q2 Earnings Insights

By Benzinga Insights

Today, 3:12 AM

Pacific Biosciences (NASDAQ:PACB) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

PACB

24 minute read

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 3:12 AM

On Friday, 422 stocks made new 52-week lows.

AAT

57 minute read

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 3:12 AM

On Friday, 1043 companies hit new 52-week lows.

AAOI

27 minute read

Earnings Scheduled For May 4, 2022

By Benzinga Insights

Today, 3:12 AM

Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.

ABC